<code id='48FE08ADCF'></code><style id='48FE08ADCF'></style>
    • <acronym id='48FE08ADCF'></acronym>
      <center id='48FE08ADCF'><center id='48FE08ADCF'><tfoot id='48FE08ADCF'></tfoot></center><abbr id='48FE08ADCF'><dir id='48FE08ADCF'><tfoot id='48FE08ADCF'></tfoot><noframes id='48FE08ADCF'>

    • <optgroup id='48FE08ADCF'><strike id='48FE08ADCF'><sup id='48FE08ADCF'></sup></strike><code id='48FE08ADCF'></code></optgroup>
        1. <b id='48FE08ADCF'><label id='48FE08ADCF'><select id='48FE08ADCF'><dt id='48FE08ADCF'><span id='48FE08ADCF'></span></dt></select></label></b><u id='48FE08ADCF'></u>
          <i id='48FE08ADCF'><strike id='48FE08ADCF'><tt id='48FE08ADCF'><pre id='48FE08ADCF'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:54389
          Stock illustration of computer and medication
          Adobe

          Half a year after selling its assets at bankruptcy auction, Pear Therapeutics’ most significant digital treatments will find a new life as part of PursueCare, which provides online addiction care and mental health counseling.

          PursueCare today announced it had raised a $20 million Series B round and that it had acquired Pear’s portfolio of apps that treat people with addiction problems. PursueCare’s CEO Nick Mercadante told STAT the company hopes to develop the market for the treatments where Pear could not, by taking advantage of its access to patients and insurers.

          advertisement

          “My view of digital therapeutics is that those point solutions really need a horse to draw the carriage,” he said. “You need a willing and capable service provider that says we’re going to make this a big part of real world care and… then show the health plans how it can save them money in the real world without extra thinking.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?
          Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

          Advancesingenetherapycouldeventually"cure"manyformsofcongenitaldeafness.Thechangeshavemanydeafpeople

          read more
          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more

          Medicare must police algorithms in Medicare Advantage, Dems say

          Reps.JerryNadler(D-N.Y.)andJudyChu(D-Calif.)JoshuaRoberts/GettyImagesHouseDemocratsareraisingconcern